Detalhe da pesquisa
1.
Characterization of multi-DAA resistance using a novel hepatitis C virus genotype 3a infectious culture system.
Hepatology
; 78(2): 621-636, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36999539
2.
Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication.
Antimicrob Agents Chemother
; 65(7): e0009721, 2021 06 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33903110
3.
Cell Culture Studies of the Efficacy and Barrier to Resistance of Sofosbuvir-Velpatasvir and Glecaprevir-Pibrentasvir against Hepatitis C Virus Genotypes 2a, 2b, and 2c.
Antimicrob Agents Chemother
; 64(3)2020 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31818814
4.
Efficacy of NS5A Inhibitors Against Hepatitis C Virus Genotypes 1-7 and Escape Variants.
Gastroenterology
; 154(5): 1435-1448, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29274866
5.
Robust HCV Genotype 3a Infectious Cell Culture System Permits Identification of Escape Variants With Resistance to Sofosbuvir.
Gastroenterology
; 151(5): 973-985.e2, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27453546
6.
Productive homologous and non-homologous recombination of hepatitis C virus in cell culture.
PLoS Pathog
; 9(3): e1003228, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23555245
7.
Breadth of neutralization and synergy of clinically relevant human monoclonal antibodies against HCV genotypes 1a, 1b, 2a, 2b, 2c, and 3a.
Hepatology
; 60(5): 1551-62, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25043937
8.
Analysis of functional differences between hepatitis C virus NS5A of genotypes 1-7 in infectious cell culture systems.
PLoS Pathog
; 8(5): e1002696, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22654662
9.
Neutralizing antibody and CD8+ T cell responses following BA.4/5 bivalent COVID-19 booster vaccination in adults with and without prior exposure to SARS-CoV-2.
Front Immunol
; 15: 1353353, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38571939
10.
Adapted J6/JFH1-based Hepatitis C virus recombinants with genotype-specific NS4A show similar efficacies against lead protease inhibitors, alpha interferon, and a putative NS4A inhibitor.
Antimicrob Agents Chemother
; 57(12): 6034-49, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24060868
11.
Analysis of hepatitis C virus core/NS5A protein co-localization using novel cell culture systems expressing core-NS2 and NS5A of genotypes 1-7.
J Gen Virol
; 94(Pt 10): 2221-2235, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23907394
12.
Identification of the viral and cellular microRNA interactomes during SARS-CoV-2 infection.
Cell Rep
; 42(4): 112282, 2023 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36961814
13.
Differential activity of nucleotide analogs against tick-borne encephalitis and yellow fever viruses in human cell lines.
Virology
; 585: 179-185, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37356253
14.
Durability and breadth of neutralisation following multiple antigen exposures to SARS-CoV-2 infection and/or COVID-19 vaccination.
EBioMedicine
; 89: 104475, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36870117
15.
Recombinant HCV variants with NS5A from genotypes 1-7 have different sensitivities to an NS5A inhibitor but not interferon-α.
Gastroenterology
; 140(3): 1032-42, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21111742
16.
Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication.
Viruses
; 14(2)2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35215765
17.
Analysis of Neutralization Titers against SARS-CoV-2 in Health-Care Workers Vaccinated with Prime-Boost mRNA-mRNA or Vector-mRNA COVID-19 Vaccines.
Vaccines (Basel)
; 10(1)2022 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35062736
18.
Neutralisation titres against SARS-CoV-2 are sustained 6 months after onset of symptoms in individuals with mild COVID-19.
EBioMedicine
; 71: 103519, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34419923